Page last updated: 2024-08-25

1-ethyl-2-benzimidazolinone and Colitis Gravis

1-ethyl-2-benzimidazolinone has been researched along with Colitis Gravis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Broncy, L; Gülow, K; Kunst, C; Müller, M; Pollinger, K; Süss, C; Wölfel, G	1

Other Studies

1 other study(ies) available for 1-ethyl-2-benzimidazolinone and Colitis Gravis

Article	Year
KCNN4 Expression Is Elevated in Inflammatory Bowel Disease: This Might Be a Novel Marker and Therapeutic Option Targeting Potassium Channels. Journal of gastrointestinal and liver diseases : JGLD, 2020, Dec-12, Volume: 29, Issue:4 Topics: Adult; Aged; Animals; Benzimidazoles; Benzothiazoles; Case-Control Studies; Cell Line; Colitis, Ulcerative; Crohn Disease; Female; Humans; Intermediate-Conductance Calcium-Activated Potassium Channels; Intestinal Mucosa; Male; Membrane Transport Modulators; Middle Aged; Molecular Targeted Therapy; Permeability; Rats; Up-Regulation	2020

Article

Year

KCNN4 Expression Is Elevated in Inflammatory Bowel Disease: This Might Be a Novel Marker and Therapeutic Option Targeting Potassium Channels.

Journal of gastrointestinal and liver diseases : JGLD, 2020, Dec-12, Volume: 29, Issue:4

Topics: Adult; Aged; Animals; Benzimidazoles; Benzothiazoles; Case-Control Studies; Cell Line; Colitis, Ulcerative; Crohn Disease; Female; Humans; Intermediate-Conductance Calcium-Activated Potassium Channels; Intestinal Mucosa; Male; Membrane Transport Modulators; Middle Aged; Molecular Targeted Therapy; Permeability; Rats; Up-Regulation

2020